Adult Dacryocystocele Among Patients With Epiphora

NCT ID: NCT04240938

Last Updated: 2020-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-01

Study Completion Date

2019-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with lacrimal dacryocystocele were chosen for the study. Dacryocystorhinostomy were done for them after their evaluation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluation for lacrimal passage in the included patients using syringing, probing and dye disappearance test. Dacryocystorhinostomy were done for all patients and followed up for at least 6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lacrimal Passage Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Adult Dacryocystocele
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lacrimal sac mucocele

Adult patients with lacrimal sac mucocele

Group Type OTHER

Dacryocystorhinostomy

Intervention Type PROCEDURE

Anastomosis between lacrimal sac and nasal cavity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dacryocystorhinostomy

Anastomosis between lacrimal sac and nasal cavity

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lacrimal sac mucocele
* Acquired type

Exclusion Criteria

* No previous lacrimal sac surgery
* Suspected lacrimal sac malignancy
Minimum Eligible Age

19 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Farag Khalil Ibrahiem

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed F Ibrahiem, MD

Role: PRINCIPAL_INVESTIGATOR

Minia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine

Minya, Minya Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Minia2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lacrimal Deroofing for Epiphora
NCT06983717 COMPLETED
Amniotic Membrane for Dacryocystorhinostomy
NCT06226181 RECRUITING PHASE1
Partial Lacrimal Punctual Occlusion
NCT00802399 COMPLETED NA